Mercer Global Advisors Inc Adaptive Biotechnologies Corp Transaction History

Mercer Global Advisors Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 11, 2021	SELL	$37.26 - $67.74 $373,866 - $679,703	-10,034 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$45.01 - $65.47 $224,014 - $325,844	-4,977 Reduced 33.16%	10,034 $593,000
Q3 2020 Dec 10, 2020	SELL	$35.79 - $48.81 $107 - $146	-3 Reduced 0.02%	15,011 $730,000
Q2 2020 Aug 10, 2020	BUY	$24.95 - $48.38 $49 - $96	2 Added 0.01%	15,014 $726,000
Q1 2020 May 18, 2020	BUY	$16.96 - $34.16 $254,603 - $512,809	15,012 New	15,012 $417,000

202

146M

68.8K

42.5K

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $797M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

Get notified when there are updates to the investment portfolio of Mercer Global Advisors Inc , based on Form 13F filings with the SEC.

Stay updated on Mercer Global Advisors Inc with notifications on news.